To The Moon

$Sunshine Biopharma Inc.(SBFM)$ 

The Sunshine Biopharma, Inc. stock price gained 24.59% on the last trading day (Tuesday, 26th Nov 2024), rising from $2.44 to $3.14. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 30.25% from a day low at $2.38 to a day high of $3.10. The price has fallen in 6 of the last 10 days but is still up by 15.59% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 774 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $4.62 million.

Given the current short-term trend, the stock is expected to fall -13.05% during the next 3 months and, with a 90% probability hold a price between $1.82 and $2.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBFM Signals & Forecast

The Sunshine Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.39 and $2.77. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, November 21, 2024, and so far it has risen 43.40%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

Sunshine Biopharma, Inc. finds support from accumulated volume at $3.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.720 between high and low, or 30.25%. For the last week, the stock has had daily average volatility of 19.52%.

Our recommended stop-loss: $2.93 (-3.78%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (SBFM) For The Upcoming Trading Day Of Wednesday 27th

For the upcoming trading day on Wednesday, 27th we expect Sunshine Biopharma, Inc. to open at $2.84, and during the day (based on 14 day Average True Range), to move between $2.78 and $3.30, which gives a possible trading interval of +/-$0.259 (+/-8.52%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 17.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.03 (0.33%) than the resistance at $3.16 (3.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Insiders are Very Positive Buying More Shares Than They Are Selling In Sunshine Biopharma, Inc.

In the last 74 trades there were 1.09 billion shares bought and 315.42 million shares sold. The last trade was made 268 days ago by Slilaty Steve N. who bough 100 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.